EverSource Wealth Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History

EverSource Wealth Advisors’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-637	Closed	-$13.7K	–	4431
2026 Q1	$13.7K	Buy	637 +265	+71%	+$3.73K	﹤0.01%	2748
2025 Q4	$3.47K	Buy	372 +141	+61%	+$1.18K	﹤0.01%	3274
2025 Q3	$1.63K	Sell	231 -65	-22%	-$447	﹤0.01%	3576
2025 Q2	$1.92K	Sell	296 -49	-14%	-$337	﹤0.01%	3522
2025 Q1	$2.74K	Buy	345 +332	+2,554%	+$3.58K	﹤0.01%	2778
2024 Q4	$165	Buy	+13	New	+$181	﹤0.01%	3469

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EverSource Wealth Advisors's DAWN Position: Q2 2026 in Review

EverSource Wealth Advisors sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 637 shares — an estimated $13.7K sold.

EverSource Wealth Advisors first reported a position in DAWN in Q4 2024 and held it in 6 quarters. The position peaked at $13.7K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

EverSource Wealth Advisors reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 637 Day One Biopharmaceuticals shares in Q2 2026, an estimated $13.7K.
EverSource Wealth Advisors first reported a position in Day One Biopharmaceuticals in Q4 2024 and held it in 6 quarters.
EverSource Wealth Advisors's Day One Biopharmaceuticals position peaked at $13.7K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.